Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,44507,1811,1.00 [0.95-1.06],0.9729625637275824
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,43811,438,1.01 [0.91-1.12],0.8626621188116694
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,48662,330,0.98 [0.87-1.11],0.8010361879051939
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,33641,1583,1.04 [0.98-1.10],0.2033206016683456
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,48554,222,0.92 [0.79-1.07],0.2615150178275284
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,45409,177,1.00 [0.85-1.18],0.9979634218930674
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",51045,220,0.93 [0.80-1.08],0.3234645934913812
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,51055,150,0.92 [0.77-1.11],0.3972341592061178
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,44342,116,1.16 [0.95-1.42],0.1506508155621123
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,49371,240,1.02 [0.89-1.18],0.7730349890675682
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,49288,157,0.96 [0.80-1.14],0.6332681947674241
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51218,134,1.08 [0.90-1.31],0.4174847022571106
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51206,167,1.06 [0.89-1.25],0.5230146050283832
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51193,154,1.09 [0.91-1.29],0.3545938871107468
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,50507,107,0.95 [0.76-1.17],0.6120757756382627
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",48756,829,1.01 [0.93-1.09],0.8585468598999606
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,48206,279,1.01 [0.88-1.15],0.8990990537382256
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,48501,574,1.01 [0.92-1.11],0.7826975161876417
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",41045,129,0.91 [0.74-1.11],0.345343728838985
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",41448,532,1.04 [0.94-1.15],0.4400440609076597
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",41464,548,1.03 [0.94-1.14],0.4961226156335674
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23227,673,0.95 [0.87-1.04],0.2474547535516461
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18596,234,0.98 [0.85-1.14],0.7966433069704374
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41024,108,0.88 [0.71-1.09],0.2312700936711587
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,45723,1590,1.08 [1.02-1.14],0.0081146599763159
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",48652,665,1.01 [0.93-1.10],0.802928098588348
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,50292,232,0.93 [0.81-1.08],0.3631498988927046
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51379,221,0.96 [0.82-1.11],0.5764012256458064
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,50826,133,1.12 [0.93-1.35],0.2446360007394489
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,51391,136,1.10 [0.91-1.33],0.3206862502995193
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Stomach,51487,103,1.05 [0.84-1.30],0.6815761363560915
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,50939,596,0.99 [0.91-1.09],0.8785407142122593
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51400,219,0.97 [0.84-1.13],0.6934856935566492
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51410,180,0.93 [0.79-1.10],0.4105426043244373
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51286,105,0.92 [0.74-1.14],0.4560367075624293
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma, any site",51291,104,0.93 [0.75-1.16],0.5427538296576149
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi,51125,402,1.10 [0.99-1.23],0.0851352303327294
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,51427,176,1.17 [0.99-1.37],0.0641194599553732
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Other benign neoplasms of skin,51215,365,0.99 [0.88-1.11],0.9022786607771476
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of breast,27709,138,0.92 [0.76-1.11],0.3809105170265435
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Leiomyoma of uterus,27199,1001,1.03 [0.96-1.10],0.4687262943814574
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,48870,398,1.16 [1.04-1.29],0.0075571474920808
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,48220,706,1.12 [1.03-1.22],0.0061277524236618
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,48220,706,1.12 [1.03-1.22],0.0061277524236618
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),44452,932,1.05 [0.98-1.14],0.1522231588701916
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,50383,137,0.80 [0.66-0.97],0.021334333929476
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,50870,166,1.09 [0.92-1.29],0.3253930955620291
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41564,2372,1.02 [0.97-1.07],0.4121608547747462
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,48418,1089,1.04 [0.97-1.12],0.2228479446358212
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,46840,271,1.08 [0.94-1.23],0.2855937237108865
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,49095,227,1.04 [0.90-1.21],0.6148080142786874
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,46812,243,1.04 [0.90-1.19],0.6299166282108846
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,47690,1121,1.06 [0.99-1.14],0.0819702483275701
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,47654,1085,1.06 [0.98-1.13],0.1312987242149532
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,47627,372,0.93 [0.82-1.06],0.2616188441160675
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",47630,368,0.93 [0.82-1.06],0.303863712408999
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,41216,2024,1.00 [0.95-1.06],0.9351121297665232
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",39455,263,0.97 [0.84-1.11],0.6262238760719852
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,41062,1870,1.00 [0.95-1.06],0.8921654352723859
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,39292,100,1.29 [1.04-1.60],0.0195621262640378
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",39363,171,1.01 [0.85-1.19],0.9366502629104227
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Any mental disorder,43547,1312,1.02 [0.96-1.09],0.4543415237237743
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",42691,456,1.00 [0.90-1.11],0.9581403469383438
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",50675,338,0.99 [0.88-1.12],0.8983571194919735
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",50807,248,1.04 [0.90-1.20],0.5845001756961072
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,47929,114,0.88 [0.72-1.09],0.2499971284269672
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",51292,114,0.88 [0.72-1.09],0.2425757280282676
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",42349,114,0.88 [0.71-1.09],0.2332129145161292
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Alcohol dependence,47956,141,0.89 [0.73-1.07],0.215069097371725
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Smoking dependency,47844,120,1.12 [0.91-1.37],0.2764717847546917
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42343,108,0.90 [0.72-1.11],0.3221461594164589
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",42889,654,1.06 [0.97-1.15],0.20401977094095
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Depression,48284,571,1.05 [0.96-1.16],0.271326373132824
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Depression or dysthymia,42376,496,1.07 [0.97-1.18],0.1940596226097861
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",42491,256,1.02 [0.89-1.17],0.8130082923634842
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Other anxiety disorders,48560,132,0.93 [0.77-1.13],0.4755228946180574
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Neurological diseases,44006,2956,1.04 [1.00-1.08],0.0712773968394472
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,39955,264,1.04 [0.91-1.20],0.5308447962805519
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51191,210,1.06 [0.91-1.23],0.4801790595510949
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,48789,969,1.01 [0.94-1.08],0.8165243190341008
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Epilepsy,48125,305,0.89 [0.79-1.02],0.0832476400687346
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Migraine,47982,162,1.04 [0.87-1.23],0.6860097020951339
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",50881,146,1.04 [0.87-1.25],0.6383015378765063
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,49807,158,1.04 [0.87-1.24],0.6734039846742101
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,48156,336,1.07 [0.95-1.21],0.2470233603792256
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,50332,258,1.04 [0.91-1.20],0.5500543419407549
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",49136,1340,1.07 [1.00-1.14],0.0340167434953992
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",48040,244,1.06 [0.92-1.22],0.3930889351270425
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,48572,776,1.06 [0.97-1.14],0.1829528637033191
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,50881,167,1.01 [0.86-1.20],0.866750187056385
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Hemiplegia,50830,116,1.01 [0.82-1.24],0.9243418880202424
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,50493,244,0.90 [0.78-1.04],0.1644196987532676
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",50145,730,0.99 [0.91-1.08],0.8288196008401907
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,49840,425,1.03 [0.92-1.15],0.6182461954833225
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,49565,150,0.90 [0.75-1.08],0.2776914183848671
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,49656,241,1.03 [0.89-1.19],0.6847513250473386
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,49569,154,1.13 [0.95-1.35],0.1611648236669879
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,44328,323,1.06 [0.94-1.21],0.3342891658553519
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,44801,796,1.06 [0.98-1.15],0.1289410899618088
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,49463,443,1.18 [1.06-1.31],0.0016833014030357
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,50812,106,1.39 [1.13-1.71],0.0019437318003178
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,4389,106,1.33 [1.07-1.64],0.0095483429579868
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",46529,106,1.40 [1.13-1.72],0.0016179085533028
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,50124,196,1.00 [0.85-1.17],0.977860053878763
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,50035,107,1.09 [0.88-1.35],0.4470254679005374
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",50092,176,0.94 [0.79-1.11],0.436386554107508
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,50376,196,0.93 [0.79-1.09],0.340596093951994
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,51270,269,1.05 [0.92-1.20],0.5005410123127791
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,49727,203,0.97 [0.83-1.13],0.6819293436764595
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,36437,6594,1.01 [0.98-1.04],0.6180166547985855
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,50195,137,0.81 [0.66-0.98],0.031436704453005
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",38357,4547,1.05 [1.01-1.09],0.017610972965715
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertension,38425,4615,1.05 [1.01-1.09],0.0147779739572277
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33974,164,1.10 [0.92-1.31],0.2907986987356066
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",47068,2412,0.96 [0.91-1.00],0.0673644296284461
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,46102,1446,0.93 [0.88-0.99],0.0262182531648412
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49371,488,1.03 [0.93-1.14],0.5625949779716649
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,49850,967,0.98 [0.91-1.05],0.5790624597343839
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51215,192,0.97 [0.82-1.14],0.6851249995414967
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",45258,602,0.93 [0.85-1.02],0.1181254457769512
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,46540,1919,0.96 [0.91-1.02],0.1718444441157582
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,49820,220,1.10 [0.95-1.28],0.207092760973701
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,50026,457,1.06 [0.95-1.17],0.2848320786594261
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,49780,180,0.91 [0.77-1.08],0.2775027403909909
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,49782,182,0.92 [0.78-1.09],0.3244843875596264
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33983,173,0.94 [0.79-1.12],0.4809258996399841
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,42637,118,1.05 [0.86-1.29],0.6438627492550447
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,42770,251,0.88 [0.76-1.01],0.0770180733384671
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28360,236,0.91 [0.79-1.06],0.2346708263066456
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,29008,884,0.86 [0.79-0.93],0.0002292803993131
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,42656,137,1.03 [0.85-1.25],0.7608550310524446
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,42704,185,0.74 [0.62-0.87],0.0004044676985331
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",49322,416,1.01 [0.91-1.13],0.8443107705217916
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",49658,312,1.01 [0.89-1.15],0.8761478472025354
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",49726,262,1.03 [0.89-1.18],0.714226138937907
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",49883,234,1.05 [0.91-1.22],0.5018805991519277
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49091,161,0.97 [0.81-1.15],0.7055831398638899
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,49192,262,1.03 [0.90-1.19],0.6382241113689359
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),48511,281,1.07 [0.94-1.23],0.2862765796791339
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,48469,239,1.08 [0.94-1.25],0.284117940086766
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51036,229,1.09 [0.94-1.26],0.2448566014850186
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Varicose veins,49186,956,0.93 [0.87-1.00],0.0648149527717372
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypotension,49053,176,0.98 [0.83-1.16],0.794173133811555
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,41036,4134,1.05 [1.01-1.09],0.0077189963464233
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51098,215,1.10 [0.95-1.28],0.2068341035319816
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,47698,445,1.07 [0.96-1.19],0.2216041051938152
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",47642,389,1.08 [0.96-1.21],0.1849962696884288
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,49588,506,0.98 [0.89-1.09],0.7513078364225458
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,49577,495,0.98 [0.88-1.08],0.6420188386991876
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,49863,1218,1.01 [0.95-1.07],0.804126204328808
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,48832,187,1.04 [0.89-1.23],0.6024725356868311
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Nasal polyp,48893,248,1.07 [0.93-1.23],0.3148608216518085
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49430,785,1.01 [0.94-1.10],0.7331370301901168
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,49013,368,1.00 [0.89-1.12],0.967812689337136
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23643,126,0.92 [0.75-1.13],0.443592823779654
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,45971,2034,1.09 [1.03-1.14],0.0011912330934951
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Early onset COPD,49108,353,1.08 [0.96-1.22],0.2123007410976353
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",49156,401,1.09 [0.97-1.22],0.1432196547262586
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",49156,401,1.09 [0.97-1.22],0.1432196547262586
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",48001,1685,1.08 [1.03-1.14],0.0039795245300423
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Asthma,36736,1685,1.09 [1.03-1.15],0.0016326359160065
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",36201,1685,1.09 [1.03-1.15],0.0017093893111184
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",36710,1659,1.09 [1.03-1.15],0.0036826216859769
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,50721,181,0.92 [0.78-1.09],0.3482970352300639
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,48506,140,0.97 [0.80-1.17],0.7278852373191943
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",50880,140,0.97 [0.80-1.17],0.7271646093045288
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,48492,126,0.89 [0.73-1.09],0.2525144043749963
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural effusion,47292,223,0.94 [0.81-1.09],0.4003380091958085
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,47548,479,1.01 [0.91-1.12],0.8116163558889107
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,48930,216,1.10 [0.95-1.28],0.216737221742497
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,35005,11658,1.01 [0.99-1.04],0.3410813221687783
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",50421,834,1.03 [0.96-1.12],0.401802711246375
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51414,183,1.04 [0.88-1.22],0.65896793917947
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Impacted teeth,51422,170,1.07 [0.91-1.27],0.4002739263197312
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Dental caries,49800,213,1.07 [0.92-1.25],0.3619079123080683
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,49785,198,1.05 [0.90-1.23],0.533885950694576
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51395,203,1.04 [0.89-1.21],0.59721416307426
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,49778,191,0.98 [0.84-1.15],0.8314481001374168
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,49249,157,0.96 [0.80-1.14],0.6208898246970567
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51255,106,0.90 [0.72-1.12],0.3373850428391624
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,39095,546,1.00 [0.90-1.10],0.9251175952848932
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",42897,4348,1.00 [0.96-1.03],0.881471040333462
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophagitis,39230,681,1.08 [0.99-1.18],0.0660972514163647
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,39947,1398,0.98 [0.93-1.05],0.60092319113918
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,38700,151,1.05 [0.88-1.26],0.561863566115953
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,38963,414,1.04 [0.93-1.16],0.4744696528336753
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,38666,117,1.10 [0.90-1.35],0.3439339485860037
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,38855,306,0.97 [0.85-1.10],0.6255866530416029
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,38797,248,1.03 [0.89-1.19],0.6884376365638698
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51204,171,1.00 [0.84-1.19],0.9874243217348252
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,38800,251,0.91 [0.79-1.05],0.1760680277836195
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),40189,1640,0.99 [0.93-1.04],0.6152564421894451
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,51168,250,1.02 [0.89-1.18],0.7428500721018301
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,39423,874,0.99 [0.92-1.07],0.782948185040757
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,38885,336,0.95 [0.84-1.08],0.4469658266736893
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,51150,312,0.93 [0.82-1.05],0.2268126431233554
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,51118,200,0.99 [0.84-1.15],0.8641880483633946
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Hernia,45041,3262,1.04 [1.00-1.08],0.0517154135430004
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,42968,1189,0.99 [0.93-1.06],0.8716996913571788
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,42036,257,0.98 [0.85-1.13],0.8092746249860012
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ventral hernia,41983,204,0.97 [0.83-1.14],0.7080823374927688
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,43521,1742,1.09 [1.03-1.15],0.0029200890262523
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,49522,1521,1.05 [0.99-1.11],0.1237274004048658
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,40272,4019,0.99 [0.96-1.03],0.7562451706686866
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",50794,119,1.08 [0.89-1.32],0.4333374424797559
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",51341,162,1.06 [0.89-1.26],0.5126286469277133
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn disease,48163,162,1.06 [0.90-1.26],0.4831619675602832
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48123,122,1.04 [0.85-1.27],0.7035712155568385
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",51201,272,1.04 [0.91-1.19],0.5644335964789116
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,48273,272,1.04 [0.91-1.19],0.5315786599039151
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48245,244,1.06 [0.92-1.22],0.4384113618021177
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,49236,1235,1.04 [0.98-1.11],0.1829725099270588
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,49222,1221,1.04 [0.98-1.11],0.2011802983510793
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,36452,199,1.05 [0.89-1.22],0.5749747957877644
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal stricture,50548,199,1.05 [0.90-1.23],0.5506985118048611
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36385,132,1.08 [0.89-1.31],0.4297102550059157
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,37477,1224,1.02 [0.96-1.09],0.5295125935897651
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,36587,334,1.06 [0.94-1.20],0.3248458489430812
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,36836,583,1.07 [0.98-1.17],0.1436093831128023
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Constipation,48170,524,1.05 [0.95-1.16],0.3156213150406102
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,50567,173,1.05 [0.89-1.24],0.5806957557516603
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36540,287,0.94 [0.83-1.08],0.3832346882573637
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36393,140,0.98 [0.82-1.19],0.86594199329518
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38011,1758,0.99 [0.93-1.04],0.6240567958546803
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,36794,541,0.93 [0.84-1.03],0.1554415910352842
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,50538,144,1.06 [0.88-1.27],0.5503218015863006
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of liver,49827,246,0.76 [0.66-0.88],0.0003172386194964
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,49717,136,0.80 [0.66-0.98],0.0292041421467512
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",48719,1257,1.04 [0.98-1.11],0.2181742984273692
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,48474,1012,1.05 [0.98-1.12],0.2050873432746428
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholecystitis,47664,202,1.16 [0.99-1.35],0.0587501384946819
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,47563,101,1.06 [0.85-1.32],0.6011008296576981
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,47597,135,1.01 [0.84-1.23],0.8892503860051163
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),51123,135,1.01 [0.83-1.22],0.9299751350621088
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,48703,637,1.07 [0.98-1.17],0.1134395360747404
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48208,142,1.15 [0.96-1.38],0.1210596095409875
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Coeliac disease,48183,117,1.16 [0.95-1.42],0.1420396889826318
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48168,102,1.16 [0.93-1.44],0.1789034213434458
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,48469,403,1.04 [0.93-1.16],0.4482312770304103
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,GI-bleeding,48455,389,1.03 [0.92-1.16],0.5608328082552588
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,45137,3125,0.97 [0.93-1.01],0.1541977225015541
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,50560,209,1.00 [0.86-1.17],0.9936867702953164
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,50631,911,0.96 [0.90-1.04],0.3385769347084785
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,48271,1160,0.99 [0.93-1.06],0.7442105121697095
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,49641,790,0.96 [0.88-1.04],0.2670298079068679
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",49028,177,0.89 [0.76-1.06],0.1942109574387144
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,49357,506,0.97 [0.87-1.07],0.4869218102254721
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,50913,186,1.02 [0.87-1.20],0.7754797612695352
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,50871,144,1.06 [0.88-1.27],0.5618962046891203
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,50837,110,1.07 [0.87-1.32],0.5168783255531951
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,50883,116,0.87 [0.70-1.07],0.1866832628216538
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,50878,111,0.87 [0.70-1.08],0.2087112186805086
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,49836,116,1.05 [0.85-1.28],0.6671641730742602
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,50445,725,0.95 [0.87-1.03],0.2259104390530443
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,47298,187,1.02 [0.86-1.19],0.8555155350252138
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47311,200,0.80 [0.68-0.94],0.0079482748709635
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47263,152,0.83 [0.69-1.00],0.0446912876399164
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",47549,438,1.01 [0.91-1.12],0.8584295629948318
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,47502,391,0.98 [0.88-1.10],0.7228803382105167
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,37041,7979,1.03 [1.00-1.06],0.0311863748060495
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,40273,4634,1.04 [1.01-1.08],0.022329198736238
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,46398,2414,1.06 [1.02-1.11],0.0079077785248094
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,35935,296,1.21 [1.07-1.38],0.0028255588687935
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,36569,930,1.08 [1.00-1.16],0.0555419545829738
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",50629,285,1.20 [1.06-1.37],0.0047427418807678
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,50652,258,1.22 [1.07-1.40],0.003359639383303
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37942,2303,1.07 [1.01-1.12],0.0114003737568657
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",43102,2303,1.06 [1.01-1.12],0.0144502478863207
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,35782,143,1.10 [0.91-1.32],0.3395717242274098
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",50313,139,1.08 [0.89-1.31],0.4171684418305077
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,36087,448,1.02 [0.91-1.13],0.7737235229047599
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,35783,144,0.95 [0.78-1.15],0.5712111066781447
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,36201,562,1.12 [1.02-1.23],0.0179689242274086
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51152,276,1.20 [1.05-1.37],0.0075589349858721
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,36697,1058,1.05 [0.98-1.13],0.1427120874139782
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,36435,796,1.02 [0.94-1.11],0.6172267223683849
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,38215,2576,1.01 [0.97-1.06],0.5921504711015819
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35770,131,1.05 [0.87-1.28],0.5933722256647902
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36111,472,0.99 [0.89-1.10],0.8014838338325786
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35751,112,1.04 [0.84-1.28],0.7342041424949161
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35760,121,1.05 [0.86-1.29],0.6367944850230336
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,36602,963,1.02 [0.95-1.10],0.5136407613518369
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,36471,832,1.03 [0.96-1.12],0.3895537820473324
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,39811,556,0.98 [0.89-1.08],0.7046316466795004
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50347,251,1.00 [0.87-1.15],0.965740166776527
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,50207,111,1.28 [1.04-1.57],0.0188756176005886
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,44470,124,0.99 [0.81-1.21],0.9454738328777
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,44936,590,0.92 [0.84-1.01],0.0754594513123557
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,46203,1857,0.96 [0.91-1.01],0.0982699315715391
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,44726,380,0.93 [0.83-1.05],0.2445558875438004
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,44514,168,0.93 [0.78-1.11],0.4082183764504218
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",45812,1466,0.98 [0.92-1.03],0.4100336403962324
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,44448,102,1.04 [0.84-1.30],0.7159326415324709
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,44818,472,1.04 [0.94-1.15],0.4509870985534966
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,44549,203,1.04 [0.89-1.21],0.6108559678118208
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,44501,155,0.89 [0.74-1.07],0.2038882563676766
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,44631,285,0.97 [0.85-1.10],0.6200210455626056
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,44474,128,0.96 [0.79-1.17],0.6787010902538126
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,44958,612,1.01 [0.93-1.11],0.7669843724309396
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,44605,621,1.05 [0.96-1.15],0.2736938741667298
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44122,138,1.03 [0.85-1.24],0.7850873631185935
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44157,173,0.95 [0.80-1.12],0.5241601803701506
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44189,205,1.14 [0.98-1.33],0.0855931198601772
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44084,100,1.03 [0.82-1.28],0.821895422027935
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,44218,234,1.06 [0.92-1.22],0.4314656260344329
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44192,208,1.01 [0.86-1.17],0.937099962656576
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,44504,520,1.05 [0.95-1.15],0.3675224721247346
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,44090,106,0.99 [0.80-1.23],0.9331468269646036
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,44137,153,0.98 [0.81-1.17],0.7947301146399611
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,44232,248,1.09 [0.95-1.25],0.2295601476873719
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,44107,123,0.86 [0.70-1.05],0.1476463552729796
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",44874,890,1.07 [1.00-1.16],0.0635096292169679
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,44318,334,1.01 [0.89-1.14],0.9147983640727788
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,44462,478,1.08 [0.97-1.19],0.1437874240851116
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,47689,340,0.96 [0.85-1.08],0.4612554638861013
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,48128,779,0.96 [0.88-1.04],0.2698031033572067
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,47445,96,0.96 [0.77-1.21],0.7319335493906155
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,47468,119,0.96 [0.79-1.18],0.7300789661166533
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,47556,207,0.97 [0.83-1.13],0.7181834276687808
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,40838,8542,0.99 [0.96-1.01],0.3422858547444126
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,20435,1277,0.99 [0.93-1.05],0.694953649497128
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,46182,513,1.13 [1.02-1.24],0.0152961223202659
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,45809,140,1.08 [0.90-1.31],0.396306208851559
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,46385,113,1.30 [1.06-1.59],0.0115919469693282
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,46413,141,1.21 [1.01-1.45],0.0432396010852396
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,46409,137,1.15 [0.95-1.38],0.1536772700068963
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,50734,496,0.99 [0.89-1.09],0.823354004770449
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,50568,148,1.30 [1.09-1.56],0.0030550133638864
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,50593,355,0.98 [0.87-1.11],0.7829793821851418
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50413,175,1.06 [0.90-1.25],0.5111504524417911
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,47014,2100,1.00 [0.96-1.05],0.8825676925998105
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,45112,198,0.97 [0.83-1.14],0.7129169284665908
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,45072,158,1.05 [0.88-1.25],0.5863105556476592
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,45470,556,0.99 [0.90-1.09],0.8944255723959608
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45145,231,1.00 [0.86-1.16],0.9863233152632132
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,46274,1360,1.03 [0.97-1.10],0.2947586505592157
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19726,568,1.03 [0.93-1.13],0.5534245141836593
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19261,103,0.86 [0.69-1.08],0.2006988552195278
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19256,98,0.99 [0.79-1.24],0.9114118334950976
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19322,164,1.07 [0.90-1.27],0.4645012147976817
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19318,160,1.08 [0.90-1.28],0.4095100592208922
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19374,216,0.86 [0.74-1.01],0.0634600689342243
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27451,482,0.93 [0.84-1.03],0.1833569794017373
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27116,147,0.92 [0.76-1.10],0.3476837477949522
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,27139,170,0.94 [0.79-1.11],0.4634088024629225
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27086,117,0.93 [0.76-1.15],0.518764106277821
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27387,565,0.96 [0.88-1.06],0.4569068477334125
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26957,135,0.88 [0.72-1.06],0.1815628323744593
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27074,252,1.01 [0.88-1.17],0.836434651383926
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25312,4613,1.00 [0.96-1.03],0.8257236423656431
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,21062,363,1.13 [1.01-1.27],0.0377376527722579
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20794,95,1.27 [1.02-1.59],0.0322478269841329
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20869,170,1.13 [0.95-1.33],0.1664918483508014
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21497,798,1.06 [0.98-1.15],0.1254937870577783
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21105,406,0.97 [0.87-1.08],0.5606713508446737
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21666,967,0.94 [0.87-1.01],0.1019207456256487
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21017,318,0.87 [0.77-0.99],0.0314888964282
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21138,439,1.02 [0.92-1.14],0.6946314131548331
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20800,101,1.01 [0.81-1.26],0.9243910170616412
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20885,186,1.05 [0.90-1.24],0.5316033565746562
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27725,264,1.11 [0.97-1.27],0.1310956369047295
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27737,250,1.10 [0.96-1.26],0.175983744546331
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27763,141,1.17 [0.98-1.41],0.08238061526549
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27752,155,1.19 [1.00-1.41],0.0542581643137514
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20843,144,0.96 [0.80-1.16],0.7069441174387112
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20811,112,1.01 [0.82-1.25],0.9069313605000132
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20840,141,1.11 [0.92-1.34],0.2627964580454757
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27656,469,1.11 [1.01-1.23],0.0377044486591989
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",22046,1347,1.02 [0.95-1.08],0.6129295610794078
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21580,881,0.99 [0.92-1.07],0.8943125733374597
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27743,197,1.05 [0.90-1.23],0.5119167974669644
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21167,468,0.94 [0.85-1.04],0.2529501124202088
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21030,331,0.98 [0.86-1.11],0.7129655502084034
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21599,900,0.95 [0.88-1.03],0.2316199469072234
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Female infertility,20814,115,1.08 [0.88-1.33],0.4729049406016821
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20807,108,1.05 [0.85-1.30],0.6485917435323806
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27761,877,0.99 [0.91-1.07],0.7355533045668431
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27765,1203,1.00 [0.93-1.08],0.9461201077368576
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27762,479,1.02 [0.92-1.13],0.7317778329372927
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27418,135,0.94 [0.77-1.14],0.5280915047396746
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27473,190,0.97 [0.82-1.14],0.7078822267677607
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27449,166,1.08 [0.91-1.28],0.4006074029757545
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27779,164,0.92 [0.77-1.10],0.3601104659233873
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27781,161,0.92 [0.77-1.10],0.3568578694750721
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27778,415,0.89 [0.80-1.00],0.0532271779832192
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27488,125,0.72 [0.58-0.88],0.0019098300838818
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27593,230,0.92 [0.79-1.08],0.3098289984336037
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,27030,146,1.02 [0.84-1.23],0.8735643263186534
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,27084,200,0.88 [0.75-1.04],0.1321162036236897
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,27132,248,0.95 [0.82-1.10],0.472818465836374
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,27030,146,1.01 [0.84-1.22],0.929927839314716
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,27022,138,1.01 [0.84-1.23],0.880282989688749
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,27033,149,0.86 [0.71-1.04],0.1202461315071349
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26793,231,1.03 [0.89-1.20],0.7074172455976008
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26996,434,0.98 [0.87-1.09],0.6637918493654424
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27235,673,1.02 [0.93-1.12],0.6423922597691312
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27782,170,1.05 [0.89-1.25],0.5472747483537164
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26325,128,0.96 [0.79-1.18],0.7103240986964672
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26664,102,0.99 [0.79-1.24],0.9456574339352986
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27791,341,0.88 [0.78-1.00],0.0550721453242014
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27711,261,0.86 [0.74-0.99],0.0346484314821069
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27777,251,1.09 [0.95-1.26],0.2332195946887865
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27768,242,1.10 [0.95-1.27],0.2073406736090685
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",50683,122,0.93 [0.76-1.14],0.4892102733437449
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,46386,1200,0.97 [0.91-1.04],0.4029864224388173
